Hepatitis C services at harm reduction centres in the European Union: a 28-country survey

Background: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) undertook a study in the mem...

Descripción completa

Detalles Bibliográficos
Autores: Pericàs, Juan M., Bromberg, Daniel J., Ocampo, Denise, Schatz, Eberhard, Wawer, Iwona, Wysocki, Piotr, Safreed-Harmon, Kelly, Lazarus, Jeffrey V.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/135497
Acceso en línea:https://hdl.handle.net/2445/135497
Access Level:acceso abierto
Palabra clave:Hepatitis C
Països de la Unió Europea
European Union countries
id ES_91c19176ef9eaf4261e71a0c9b61c04e
oai_identifier_str oai:recercat.cat:2445/135497
network_acronym_str ES
network_name_str España
repository_id_str
spelling Hepatitis C services at harm reduction centres in the European Union: a 28-country surveyPericàs, Juan M.Bromberg, Daniel J.Ocampo, DeniseSchatz, EberhardWawer, IwonaWysocki, PiotrSafreed-Harmon, KellyLazarus, Jeffrey V.Hepatitis CPaïsos de la Unió EuropeaEuropean Union countriesBackground: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) undertook a study in the member states of the European Union (EU). It aimed to determine service providers’ understanding of the current services in their respective countries and the barriers experienced by PWID in accessing HCV testing, care and treatment services in their country. Methods: In 2017, 38 purposively selected harm reduction service providers completed a 26-item Englishlanguage online survey addressing the availability, accessibility and funding of HCV services at harm reduction centres. HCV-related data and reported findings were extracted by country or by responding organization. Results: Responses were received from all EU member states. Respondents from 23 countries reported that HCV tests are offered by harm reduction services in their countries, and eight countries reported that addiction specialists in their countries are able to prescribe HCV therapy. Almost half of the respondents (45%) said that their respective organizations had established referral systems with centres providing HCV treatment. Conclusions: Not all EU member states have harm reduction services that provide HCV tests, and many do not have established referral systems with treatment providers. Moreover, the inability of addiction specialists to prescribe HCV treatment points to missed opportunities to make treatment more accessible. Further, discrepancies were noted between the available HCV services and stakeholders’ knowledge about their availability.BioMed Central2019201920192019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion10 p.application/pdfhttps://hdl.handle.net/2445/135497Articles publicats en revistes (ISGlobal)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: http://dx.doi.org/10.1186/s12954-019-0290-xHarm Reduction Journal, 2019, vol. 16, num. 20http://dx.doi.org/ 10.1186/s12954-019-0290-xcc by (c) Pericàs et al., 2019http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/1354972026-05-29T05:05:01Z
dc.title.none.fl_str_mv Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
spellingShingle Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
Pericàs, Juan M.
Hepatitis C
Països de la Unió Europea
European Union countries
title_short Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_full Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_fullStr Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_full_unstemmed Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
title_sort Hepatitis C services at harm reduction centres in the European Union: a 28-country survey
dc.creator.none.fl_str_mv Pericàs, Juan M.
Bromberg, Daniel J.
Ocampo, Denise
Schatz, Eberhard
Wawer, Iwona
Wysocki, Piotr
Safreed-Harmon, Kelly
Lazarus, Jeffrey V.
author Pericàs, Juan M.
author_facet Pericàs, Juan M.
Bromberg, Daniel J.
Ocampo, Denise
Schatz, Eberhard
Wawer, Iwona
Wysocki, Piotr
Safreed-Harmon, Kelly
Lazarus, Jeffrey V.
author_role author
author2 Bromberg, Daniel J.
Ocampo, Denise
Schatz, Eberhard
Wawer, Iwona
Wysocki, Piotr
Safreed-Harmon, Kelly
Lazarus, Jeffrey V.
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Hepatitis C
Països de la Unió Europea
European Union countries
topic Hepatitis C
Països de la Unió Europea
European Union countries
description Background: In the context of the WHO’s 2016 Viral Hepatitis Strategy and the introduction of treatment that can cure more than 95% of cases with hepatitis C virus (HCV) infection, the European Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) undertook a study in the member states of the European Union (EU). It aimed to determine service providers’ understanding of the current services in their respective countries and the barriers experienced by PWID in accessing HCV testing, care and treatment services in their country. Methods: In 2017, 38 purposively selected harm reduction service providers completed a 26-item Englishlanguage online survey addressing the availability, accessibility and funding of HCV services at harm reduction centres. HCV-related data and reported findings were extracted by country or by responding organization. Results: Responses were received from all EU member states. Respondents from 23 countries reported that HCV tests are offered by harm reduction services in their countries, and eight countries reported that addiction specialists in their countries are able to prescribe HCV therapy. Almost half of the respondents (45%) said that their respective organizations had established referral systems with centres providing HCV treatment. Conclusions: Not all EU member states have harm reduction services that provide HCV tests, and many do not have established referral systems with treatment providers. Moreover, the inability of addiction specialists to prescribe HCV treatment points to missed opportunities to make treatment more accessible. Further, discrepancies were noted between the available HCV services and stakeholders’ knowledge about their availability.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019
2019
2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/135497
url https://hdl.handle.net/2445/135497
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: http://dx.doi.org/10.1186/s12954-019-0290-x
Harm Reduction Journal, 2019, vol. 16, num. 20
http://dx.doi.org/ 10.1186/s12954-019-0290-x
dc.rights.none.fl_str_mv cc by (c) Pericàs et al., 2019
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc by (c) Pericàs et al., 2019
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 10 p.
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv Articles publicats en revistes (ISGlobal)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869413415836975104
score 15,808905

Similares en LA Referencia